US8563522B2
(en)
|
1997-07-08 |
2013-10-22 |
The Iams Company |
Method of maintaining and/or attenuating a decline in quality of life
|
US20020035071A1
(en)
*
|
1997-07-08 |
2002-03-21 |
Josef Pitha |
Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
|
US20060116330A1
(en)
*
|
1997-07-08 |
2006-06-01 |
The Iams Company |
Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
|
US7029702B2
(en)
*
|
1998-07-07 |
2006-04-18 |
Ritter Natural Sciences Llc |
Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
|
ID29150A
(id)
*
|
1999-01-15 |
2001-08-02 |
Entpr Ireland Cs |
Penggunaan lactobacillus salivarius
|
CA2378620A1
(en)
*
|
1999-08-09 |
2001-02-15 |
Pinaki Panigrahi |
Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids
|
JP2004501978A
(ja)
*
|
2000-07-03 |
2004-01-22 |
プロベンド・プロプライエタリー・リミテッド |
エンドトキシン血症および関連する障害のプロバイオティックによる治療
|
AUPQ899700A0
(en)
*
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
CA2342040C
(en)
*
|
2000-09-21 |
2012-07-10 |
Kyowa Hakko Kogyo Co., Ltd. |
Anaerobic bacterium as a drug for cancer gene therapy
|
WO2002028402A1
(en)
|
2000-10-06 |
2002-04-11 |
Société des Produits Nestlé S.A. |
Use of probiotic lactic acid bacteria for balancing the skin's immune system
|
IT1320772B1
(it)
*
|
2000-11-02 |
2003-12-10 |
Proge Farm Srl |
Composizione farmaceutica a base di agenti attivi contro la candidaper il trattamento di disturbi della mucosa orale e intestinale
|
JPWO2002061118A1
(ja)
*
|
2001-02-01 |
2004-06-03 |
株式会社ヤクルト本社 |
発酵乳飲食品中のビフィドバクテリウム属細菌の腸内到達度評価方法
|
US20020141977A1
(en)
*
|
2001-04-02 |
2002-10-03 |
Collins John Kevin |
Immunotherapy based on dendritic cells
|
JP4671384B2
(ja)
*
|
2001-05-15 |
2011-04-13 |
雪印乳業株式会社 |
新規乳酸菌株
|
EP1264893A1
(de)
*
|
2001-06-08 |
2002-12-11 |
Teagasc Dairy Products Research Centre |
Biosynthese von CLA durch Bifidobakterien
|
US20030092163A1
(en)
*
|
2001-07-26 |
2003-05-15 |
Collins John Kevin |
Probiotic bifidobacterium strains
|
PE20030274A1
(es)
*
|
2001-07-26 |
2003-05-08 |
Alimentary Health Ltd |
Cepas de lactobacillus salivarius
|
JP5116194B2
(ja)
*
|
2001-09-04 |
2013-01-09 |
株式会社ヤクルト本社 |
炎症性腸疾患予防治療剤
|
MXPA04001999A
(es)
*
|
2001-09-05 |
2004-07-16 |
Vsl Pharmaceuticals Inc |
Bacterias de acido lactico que comprende dinucleotidos de citosina-guanina no metilados para usarse en terapia.
|
GB0124580D0
(en)
*
|
2001-10-12 |
2001-12-05 |
Univ Reading |
New composition
|
JP3875237B2
(ja)
|
2001-12-07 |
2007-01-31 |
森永乳業株式会社 |
ビフィドバクテリウム・ロンガム
|
US6941649B2
(en)
*
|
2002-02-05 |
2005-09-13 |
Force10 Networks, Inc. |
Method of fabricating a high-layer-count backplane
|
DE10206995B4
(de)
*
|
2002-02-19 |
2014-01-02 |
Orthomol Pharmazeutische Vertriebs Gmbh |
Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
|
WO2003105893A2
(en)
*
|
2002-06-13 |
2003-12-24 |
Alimentary Health Limited |
Probiotic therapies
|
US8168170B2
(en)
|
2002-10-03 |
2012-05-01 |
The Procter And Gamble Company |
Compositions having an inner core and at least three surrounding layers
|
IL152127A0
(en)
|
2002-10-06 |
2003-05-29 |
Bio Balance Corp |
Probiotic compositions for the treatment of inflammatory bowel disease
|
US7105336B2
(en)
*
|
2002-10-07 |
2006-09-12 |
Biogaia Ab |
Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
|
US7740838B2
(en)
*
|
2002-12-05 |
2010-06-22 |
Danisco A/S |
Bacterial composition and its use
|
US7179460B2
(en)
*
|
2002-12-05 |
2007-02-20 |
Danisco A/S |
Bacterial composition and its use
|
JP2004189672A
(ja)
*
|
2002-12-11 |
2004-07-08 |
Gen Corp:Kk |
抗下痢症組成物
|
US20040208863A1
(en)
*
|
2003-01-30 |
2004-10-21 |
James Versalovic |
Anti-inflammatory activity from lactic acid bacteria
|
SE526711C2
(sv)
*
|
2003-01-31 |
2005-10-25 |
Probi Ab |
Nya stammar av Bifidobacterium med förmåga att överleva i magtarmkanalen och producera glutamin in vivo, samt kompositioner och användningar därav
|
US20040197304A1
(en)
|
2003-04-01 |
2004-10-07 |
The Procter & Gamble Company And Alimentary Health, Ltd. |
Methods of determining efficacy of treatments of inflammatory diseases of the bowel
|
US20040265279A1
(en)
*
|
2003-05-08 |
2004-12-30 |
Timothy Dinan |
Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic pitiuitary-adrenal axis over-activity
|
US7749509B2
(en)
*
|
2003-08-29 |
2010-07-06 |
Cobb And Company, Llp |
Treatment of autism using probiotic composition
|
US8192733B2
(en)
|
2003-08-29 |
2012-06-05 |
Cobb & Associates |
Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
|
US7731976B2
(en)
*
|
2003-08-29 |
2010-06-08 |
Cobb And Company, Llp |
Treatment of irritable bowel syndrome using probiotic composition
|
US7759105B2
(en)
*
|
2003-08-29 |
2010-07-20 |
Cobb & Company, Llp |
Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
|
US20060177424A1
(en)
*
|
2003-08-29 |
2006-08-10 |
Cobb Mark L |
Treatment of disease states and adverse physiological conditions utilizing anti-fungal compositions
|
GB0323039D0
(en)
*
|
2003-10-01 |
2003-11-05 |
Danisco |
Method
|
EP1706126A4
(de)
*
|
2003-12-04 |
2009-07-01 |
Biofilms Strategies Inc |
Verfahren und zusammensetzungen zur verhinderung der ausbildung von biofilmen, reduzierung bestehender biofilme, und zur reduzierung bestehender biofilme und zur reduzierung von bakterienpopulationen
|
US8894991B2
(en)
|
2003-12-19 |
2014-11-25 |
The Iams Company |
Canine probiotic Lactobacilli
|
US7785635B1
(en)
|
2003-12-19 |
2010-08-31 |
The Procter & Gamble Company |
Methods of use of probiotic lactobacilli for companion animals
|
US20050158294A1
(en)
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
US8877178B2
(en)
|
2003-12-19 |
2014-11-04 |
The Iams Company |
Methods of use of probiotic bifidobacteria for companion animals
|
US20050152884A1
(en)
|
2003-12-19 |
2005-07-14 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria globosum
|
WO2005072718A1
(ja)
*
|
2004-01-28 |
2005-08-11 |
Kurume University |
乳清発酵物を含有する医薬組成物
|
US7862808B2
(en)
*
|
2004-07-01 |
2011-01-04 |
Mead Johnson Nutrition Company |
Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
|
WO2006012536A2
(en)
*
|
2004-07-22 |
2006-02-02 |
Ritter Andrew J |
Methods and compositions for treating lactose intolerance
|
KR100568036B1
(ko)
|
2004-08-12 |
2006-04-07 |
하남주 |
장기능 활성화 및 면역기능 강화작용을 하는비피도박테리움 균주 및 이를 함유하는 생균제제
|
JP2006166829A
(ja)
*
|
2004-12-17 |
2006-06-29 |
Best Ecology:Kk |
アイスサプリメント及びその製造方法
|
WO2006097949A1
(en)
*
|
2005-03-16 |
2006-09-21 |
Actial Farmacêutica, Lda. |
Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
|
EP1865795A1
(de)
|
2005-04-08 |
2007-12-19 |
Alimentary Health Limited |
Verfahren zur verwendung oral verabreichter probiotischer bifidobakterien zum nutzen der menschlichen schönheit
|
AU2011205121B2
(en)
*
|
2005-04-08 |
2012-07-05 |
Alimentary Health Ltd |
Method of use of orally administered probiotic bifidobacteria for human beauty benefits
|
US20060228448A1
(en)
|
2005-04-11 |
2006-10-12 |
The Iams Company |
Pet food compositions comprising two components
|
US7303745B2
(en)
*
|
2005-04-15 |
2007-12-04 |
Bristol-Myers Squibb Company |
Method for preventing or treating the development of respiratory allergies
|
PL1885383T3
(pl)
|
2005-05-31 |
2017-06-30 |
Iams Europe B.V. |
Kocie probiotyczne bifidobakterie
|
AU2006253006B8
(en)
|
2005-05-31 |
2011-09-15 |
Alimentary Health Ltd |
Feline probiotic Lactobacilli
|
CN101374425A
(zh)
*
|
2005-07-20 |
2009-02-25 |
荷兰联合利华有限公司 |
含有有益细菌的可食用产品
|
ITMI20051510A1
(it)
*
|
2005-08-02 |
2007-02-03 |
Proge Farm Srl |
Uso di specifici batteri lattici per la preparazione di composizioni iunomodulanti
|
RU2297835C1
(ru)
*
|
2005-09-26 |
2007-04-27 |
Закрытое акционерное общество "Партнер" |
Препарат для лечения неинфекционных воспалительных болезней кишечника
|
WO2007038466A2
(en)
*
|
2005-09-27 |
2007-04-05 |
Cobb & Company |
Treatment of bipolar disorder utilizing anti-fungal compositions
|
US7943328B1
(en)
|
2006-03-03 |
2011-05-17 |
Prometheus Laboratories Inc. |
Method and system for assisting in diagnosing irritable bowel syndrome
|
DK2002842T3
(da)
*
|
2006-03-31 |
2012-05-07 |
Morinaga Milk Industry Co Ltd |
Fremgangsmåde til fremstilling af interleukinproduktionsregulator
|
WO2007133188A1
(en)
*
|
2006-05-01 |
2007-11-22 |
Cobb & Company, Llp |
Treatment of disease states and adverse physiological conditions utilizing anti-fungal compositions
|
US20080085524A1
(en)
|
2006-08-15 |
2008-04-10 |
Prometheus Laboratories Inc. |
Methods for diagnosing irritable bowel syndrome
|
US20080118473A1
(en)
*
|
2006-11-01 |
2008-05-22 |
The Procter & Gamble Company |
Methods of treating a respiratory condition comprising probiotic treatment
|
US7964238B2
(en)
*
|
2007-01-29 |
2011-06-21 |
Guardian Industries Corp. |
Method of making coated article including ion beam treatment of metal oxide protective film
|
PL2124966T3
(pl)
|
2007-02-01 |
2016-01-29 |
Iams Europe B V |
Sposób zmniejszania reakcji zapalnej i stresu u ssaków za pomocą antymetabolitów glukozy, awokado lub ekstraktów awokado
|
WO2008101450A1
(de)
*
|
2007-02-22 |
2008-08-28 |
Schrezenmeir Juergen |
Probiotische, gram-positive bakterien zur prophylaxe, unterdrückung oder eliminierung von allergischen reaktionen bei menschen
|
EP2114423B2
(de)
*
|
2007-02-28 |
2020-01-01 |
MJN U.S. Holdings LLC |
Inaktivierte lactobacillus rhammosus gg zur behandlung von systemischer entzündung in säuglingen
|
US20080241226A1
(en)
*
|
2007-03-27 |
2008-10-02 |
Abeln Susan L |
Methods and Kits For Administering Probiotics
|
AU2008231467A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Alimentary Health Limited |
Probiotic Bifidobacterium strains
|
NZ580005A
(en)
*
|
2007-03-28 |
2012-03-30 |
Alimentary Health Ltd |
Probiotic bifidobacterium strain 41382
|
PL2176299T3
(pl)
*
|
2007-05-04 |
2017-11-30 |
Alimentary Health Limited |
Polisacharyd wyizolowany z Bifidobacterium infantis 35624 (NCIMB 41003)
|
ES2611277T3
(es)
|
2007-06-27 |
2017-05-08 |
Laboratorios Ordesa, S.L. |
Péptidos contra una infección por rotavirus
|
JP2009057346A
(ja)
*
|
2007-09-03 |
2009-03-19 |
Kirin Holdings Co Ltd |
免疫バランス調節用組成物
|
FR2921795B1
(fr)
*
|
2007-10-03 |
2011-04-29 |
Gervais Danone Sa |
Utilisation d'une souche de bifidobacterium,pour la preparation d'une composition destinee a la prevention et/ou au traitement de manifestations de type allergique
|
CA2706600A1
(en)
*
|
2007-11-26 |
2009-06-04 |
Plant Bioscience Limited |
Novel polypeptides having endolysin activity and uses thereof
|
US20110223248A1
(en)
*
|
2007-12-12 |
2011-09-15 |
Ritter Pharmaceuticals, Inc. |
Methods and compositions for treating lactose intolerance
|
ES2395838T3
(es)
*
|
2007-12-21 |
2013-02-15 |
Compagnie Gervais Danone |
Método para disminuir el contorno abdominal administrando una bacteria del tipo Bifidobacterium
|
ES2343499B1
(es)
*
|
2007-12-24 |
2011-06-10 |
Consejo Superior De Investigaciones Cientificas |
Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten.
|
EP2110028A1
(de)
|
2008-04-15 |
2009-10-21 |
Nestec S.A. |
Bifidobacterium longum und hippocampale BDNF-Expression
|
US9771199B2
(en)
|
2008-07-07 |
2017-09-26 |
Mars, Incorporated |
Probiotic supplement, process for making, and packaging
|
EP2293802A4
(de)
*
|
2008-06-25 |
2011-11-09 |
Ritter Pharmaceuticals Inc |
Lactosezusammensetzungen mit reduziertem lactosegehalt
|
US9232813B2
(en)
*
|
2008-07-07 |
2016-01-12 |
The Iams Company |
Probiotic supplement, process for making, and packaging
|
WO2010003916A1
(en)
*
|
2008-07-11 |
2010-01-14 |
Chr. Hansen A/S |
New probiotic bifidobacterium longum
|
RU2453320C2
(ru)
*
|
2008-08-05 |
2012-06-20 |
Виктор Владимирович Чалов |
Композиция для перорального применения, содержащая непатогенные микроорганизмы, обладающая способностью нормализовать микрофлору кишечника (варианты)
|
CA2792390C
(en)
*
|
2008-09-11 |
2016-10-25 |
The Iams Company |
Animal feed kibble with protein-based core and related methods
|
US20100074870A1
(en)
*
|
2008-09-19 |
2010-03-25 |
Bristol-Myers Squibb Company |
Probiotic infant products
|
KR101057357B1
(ko)
|
2008-09-22 |
2011-08-17 |
광주과학기술원 |
유산균 및 콜라겐을 유효성분으로 포함하는 관절염 예방 또는 치료용 약제학적 조성물 및 식품 조성물
|
CA2852487C
(en)
*
|
2008-11-11 |
2017-01-31 |
Alimentary Health Limited |
Bifidobacterium longum strain ah1714
|
CA2752800C
(en)
|
2009-02-24 |
2017-12-05 |
Ritter Pharmaceuticals, Inc. |
Prebiotic formulations and methods of use
|
GB0908949D0
(en)
|
2009-05-26 |
2009-07-01 |
Plant Bioscience Ltd |
Novel polypeptides having endolysin activity and uses thereof
|
US20100330151A1
(en)
|
2009-06-25 |
2010-12-30 |
Mary Elaine Freeland |
Method of Promoting Gastrointestinal Health Using a Combination of a Probiotic Microorganism and Chocolate
|
US20110027412A1
(en)
|
2009-07-31 |
2011-02-03 |
Kris Eugene Spence |
Compositions and Methods for Promoting Gastrointestinal and/or Cardiovascular Health
|
US10104903B2
(en)
|
2009-07-31 |
2018-10-23 |
Mars, Incorporated |
Animal food and its appearance
|
ES2664828T3
(es)
|
2009-08-25 |
2018-04-23 |
Nestec S.A. |
Bifidobacterium longum y trastornos GI funcionales
|
US8765706B2
(en)
|
2009-09-02 |
2014-07-01 |
Kyoto Prefectural Public University Corporation |
Composition comprising rna derived from lactic acid bacterium as effective component
|
EP3260126A1
(de)
*
|
2009-10-09 |
2017-12-27 |
Prothera, Inc. |
Zusammensetzungen und verfahren mit pediokokken zur reduzierung mindestens eines symptoms für autismusspektrumserkrankungen bei einem patienten mit diagnostizierter autismusspektrumserkrankung
|
MX2012005524A
(es)
*
|
2009-11-11 |
2013-04-03 |
Procter & Gamble |
Cepa de probioticos bifidobacterium.
|
ES2610829T3
(es)
*
|
2009-11-11 |
2017-05-03 |
Alimentary Health Limited |
Cepa de Bifidobacterium
|
AU2011209407B2
(en)
|
2010-01-28 |
2014-02-27 |
Ab-Biotics S.A. |
Probiotic composition for use in the treatment of bowel inflammation
|
EP3181684B1
(de)
|
2010-02-01 |
2019-05-29 |
Rebiotix Inc. |
Bakterientherapie für clostridium-difficile-colitis
|
FR2955774A1
(fr)
|
2010-02-02 |
2011-08-05 |
Aragan |
Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation
|
WO2011118060A1
(ja)
*
|
2010-03-26 |
2011-09-29 |
株式会社明治 |
腸管免疫の抑制剤のスクリーニング方法
|
RU2451740C2
(ru)
*
|
2010-04-26 |
2012-05-27 |
Татьяна Александровна Левченко |
ШТАММ Bifidobacterium longum АБД-7, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПОЛУЧЕНИЯ БИФИДОСОДЕРЖАЩЕЙ ПРОДУКЦИИ
|
RU2451741C2
(ru)
*
|
2010-04-26 |
2012-05-27 |
Татьяна Александровна Левченко |
ШТАММ Bifidobacterium longum АБД-3, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПОЛУЧЕНИЯ БИФИДОСОДЕРЖАЩЕЙ ПРОДУКЦИИ
|
EP3202406A1
(de)
|
2010-04-28 |
2017-08-09 |
Ritter Pharmaceuticals, Inc. |
Präbiotische formulierungen und deren verwendungen
|
WO2011148219A1
(en)
*
|
2010-05-28 |
2011-12-01 |
Compagnie Gervais Danone |
Probiotic strains for use in improving the enteric nervous system
|
CN102269858A
(zh)
|
2010-06-02 |
2011-12-07 |
北京智朗芯光科技有限公司 |
自动聚焦系统和自动聚焦方法
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性t細胞の増殖または集積を誘導する作用を有する組成物
|
FR2962045B1
(fr)
*
|
2010-07-05 |
2012-08-17 |
Bifinove |
Complexe macromoleculaire d'origine bacterienne et utilisation dudit complexe moleculaire pour prevenir et traiter les rhumatismes inflammatoires
|
BR112013002667B1
(pt)
|
2010-08-04 |
2020-02-04 |
Thomas Julius Borody |
composições para transplante da flora intestinal e métodos para fazê-las e usá-las e dispositivos para administrá-las
|
CA2817529A1
(en)
*
|
2010-11-11 |
2012-05-18 |
Nestec S.A. |
Frozen confections containing probiotic micro-organisms
|
EP2481299B1
(de)
|
2011-01-31 |
2016-12-07 |
Dr. Fischer Gesundheitsprodukte GmbH |
Bifidobacterium-bifidum-stämme zur anwendung bei magen-darm-erkrankungen
|
WO2012122478A1
(en)
|
2011-03-09 |
2012-09-13 |
Regents Of The University Of Minnesota |
Compositions and methods for transplantation of colon microbiota
|
WO2012140636A1
(en)
*
|
2011-04-11 |
2012-10-18 |
Alimentary Health Limited |
A probiotic formulation
|
RU2460777C1
(ru)
*
|
2011-04-21 |
2012-09-10 |
Общество с ограниченной ответственностью "Бифилюкс" |
Штамм bifidobacterium longum, используемый для получения бифидосодержащей продукции
|
GB201112091D0
(en)
|
2011-07-14 |
2011-08-31 |
Gt Biolog Ltd |
Bacterial strains isolated from pigs
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
KR101355440B1
(ko)
|
2011-10-26 |
2014-02-05 |
주식회사한국야쿠르트 |
류마티스 관절염 예방 효능을 갖는 락토바실러스 헬베티쿠스 에이취와이7801 및 이를 유효성분으로 함유하는 제품
|
CN103131647B
(zh)
*
|
2011-11-29 |
2017-06-27 |
上海上药信谊药厂有限公司 |
婴儿双歧杆菌及其制剂
|
CN116942833A
(zh)
|
2011-12-01 |
2023-10-27 |
国立大学法人 东京大学 |
诱导调节性t细胞的增殖或积累的人源细菌
|
US9856451B2
(en)
*
|
2011-12-28 |
2018-01-02 |
Yamada Bee Company Inc. |
Lactic acid bacterium having IgA production promoting activity, and use thereof
|
EP2828375B1
(de)
|
2012-01-19 |
2017-11-22 |
University College Cork-National University of Ireland, Cork |
Gaba-erzeugende, aus dem menschlichen magen-darm-trakt stammende kultivierbare bakterie
|
US9173910B2
(en)
|
2012-02-29 |
2015-11-03 |
The General Hospital Corporation |
Compositions of microbiota and methods related thereto
|
BR112014024159A2
(pt)
|
2012-03-29 |
2017-06-20 |
Therabiome Llc |
Formulações de vacina oral específicas do local gastrintestinal , ativas no íleo e apêndice.
|
WO2013176774A1
(en)
|
2012-05-25 |
2013-11-28 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
EP2925332A4
(de)
|
2012-08-20 |
2016-12-21 |
Boris Markosian |
Plazentale impftherapie gegen krebs
|
FR2999601B1
(fr)
*
|
2012-12-17 |
2015-01-30 |
Urgo Lab |
Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis
|
US9907755B2
(en)
|
2013-03-14 |
2018-03-06 |
Therabiome, Llc |
Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
|
KR101434220B1
(ko)
*
|
2013-03-26 |
2014-08-28 |
삼육대학교산학협력단 |
다제내성균에 대한 저해 활성을 갖는 신규 유산균
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
US9511100B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US10383901B2
(en)
|
2013-06-05 |
2019-08-20 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9675648B2
(en)
|
2013-06-05 |
2017-06-13 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9782445B2
(en)
|
2013-06-05 |
2017-10-10 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9511099B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9694039B2
(en)
|
2013-06-05 |
2017-07-04 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
CN105407728A
(zh)
|
2013-07-21 |
2016-03-16 |
霍勒拜欧姆公司 |
用于微生物组表征、监测和治疗的方法和系统
|
JP6431080B2
(ja)
|
2014-01-24 |
2018-11-28 |
ザ プロクター アンド ギャンブル カンパニー |
微生物を含むフィラメント及びその作製方法
|
US20150209469A1
(en)
|
2014-01-24 |
2015-07-30 |
The Procter & Gamble Company |
Web Comprising a Microorganism-Containing Fibrous Element and Methods for Making Same
|
US20150209468A1
(en)
|
2014-01-24 |
2015-07-30 |
The Procter & Gamble Company |
Hygiene article containing microorganism
|
CA2964480A1
(en)
|
2014-10-31 |
2016-05-06 |
Whole Biome Inc. |
Methods and compositions relating to microbial treatment and diagnosis of disorders
|
SI3065748T1
(en)
|
2014-12-23 |
2018-05-31 |
4D Pharma Research Limited |
Severe bacteroid tethethioomycron and its use in reducing inflammation
|
AU2015370665B2
(en)
|
2014-12-23 |
2020-05-14 |
4D Pharma Research Limited |
Pirin polypeptide and immune modulation
|
CA2975217C
(en)
|
2015-02-13 |
2023-08-15 |
Mars, Incorporated |
Pet food feeding system
|
EP3288394A4
(de)
|
2015-04-28 |
2019-01-23 |
Mars, Incorporated |
Verfahren zur herstellung eines sterilisierten haustier-nassfutterprodukts
|
KR102561989B1
(ko)
|
2015-05-14 |
2023-07-31 |
핀치 테라퓨틱스 홀딩스 엘엘씨 |
대변 균무리 이식용 조성물, 및 이의 제조 및 사용 방법, 및 이의 전달을 위한 장치
|
KR102534545B1
(ko)
|
2015-05-22 |
2023-05-18 |
아리조나 보드 오브 리젠츠 온 비하프 오브 아리조나 스테이트 유니버시티 |
자폐 스펙트럼 장애 및 관련된 증상을 치료하는 방법
|
RU2017141448A
(ru)
*
|
2015-06-01 |
2019-07-15 |
Зэ Юниверсити Оф Чикаго |
Лечение рака путем манипуляций с комменсальной микрофлорой
|
US20160354507A1
(en)
|
2015-06-07 |
2016-12-08 |
The Procter & Gamble Company |
Article of commerce containing absorbent article
|
US10828340B2
(en)
|
2015-06-09 |
2020-11-10 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
US10905726B2
(en)
|
2015-06-09 |
2021-02-02 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
US10799539B2
(en)
|
2015-06-09 |
2020-10-13 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
PL3307289T3
(pl)
|
2015-06-09 |
2022-01-17 |
Rebiotix, Inc. |
Sposoby wytwarzania kompozycji do terapii przywracającej mikrobiotę (mrt)
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
DK3240554T3
(da)
|
2015-06-15 |
2019-10-28 |
4D Pharma Res Ltd |
Blautia stercosis og wexlerae til anvendelse til behandling af inflammatoriske og autoimmune sygdomme
|
RS59662B1
(sr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Kompozicije koje sadrže bakterijske sojeve
|
MD3307288T2
(ro)
|
2015-06-15 |
2019-12-31 |
4D Pharma Res Ltd |
Compoziții care conțin tulpini bacteriene
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
US20170020750A1
(en)
|
2015-07-23 |
2017-01-26 |
The Procter & Gamble Company |
Patch containing microorganism
|
US10233433B2
(en)
|
2015-08-27 |
2019-03-19 |
Alimentary Health Ltd. |
Bifidobacterium longum
|
US20180280453A1
(en)
|
2015-08-27 |
2018-10-04 |
Alimentary Health Limited |
Use of bifidobacterium longum and an exopolysaccharide produced thereby
|
WO2017060698A1
(en)
|
2015-10-05 |
2017-04-13 |
Liam O'mahony |
Use of akkermansia muciniphila for treating inflammatory conditions
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
KR20180120795A
(ko)
|
2015-11-20 |
2018-11-06 |
4디 파마 리서치 리미티드 |
박테리아성 균주를 함유한 조성물
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201612191D0
(en)
|
2016-07-13 |
2016-08-24 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
CN108698839B
(zh)
*
|
2016-03-04 |
2022-03-01 |
加州理工学院 |
新的锗硅酸盐组合物及其制备方法
|
EP3520801A1
(de)
|
2016-03-04 |
2019-08-07 |
4D Pharma Plc |
Zusammensetzungen mit bakteriellen blautia-stämmen zur behandlung von viszeraler überempfindlichkeit
|
RU2659240C2
(ru)
*
|
2016-05-23 |
2018-06-29 |
федеральное государственное бюджетное образовательное учреждение высшего образования "Кемеровский государственный университет" (КемГУ) |
Способ получения функционального продукта питания для реабилитации онкологических больных
|
US20170360848A1
(en)
|
2016-06-15 |
2017-12-21 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods for treating autism spectrum disorder and associated symptoms
|
US10849936B2
(en)
|
2016-07-01 |
2020-12-01 |
Regents Of The University Of Minnesota |
Compositions and methods for C. difficile treatment
|
TW201821093A
(zh)
|
2016-07-13 |
2018-06-16 |
英商4D製藥有限公司 |
包含細菌菌株之組合物
|
US20180036352A1
(en)
|
2016-08-03 |
2018-02-08 |
Crestovo Holdings Llc |
Methods for treating ulcerative colitis
|
US10092601B2
(en)
|
2016-10-11 |
2018-10-09 |
Crestovo Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
US11213549B2
(en)
|
2016-10-11 |
2022-01-04 |
Finch Therapeutics Holdings Llc |
Compositions and method for treating primary sclerosing cholangitis and related disorders
|
US11026978B2
(en)
|
2016-10-11 |
2021-06-08 |
Finch Therapeutics Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
IT201600121481A1
(it)
*
|
2016-11-30 |
2018-05-30 |
Sintal Dietetics Srl |
L. salivarius sgl03: attività probiotiche e produzione di proteine antimicrobiche
|
GB201621123D0
(en)
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
CN107043705A
(zh)
*
|
2016-12-30 |
2017-08-15 |
大连医科大学 |
用于建立临床营养菌种资源库的益生菌筛选方法
|
RU2752157C2
(ru)
*
|
2017-01-31 |
2021-07-23 |
Юниверсити-Индастри Кооперейшн Груп Оф Кюн Хее Юниверсити |
Новые молочнокислые бактерии и их применение
|
CN110392734A
(zh)
|
2017-02-28 |
2019-10-29 |
营养健康有限公司 |
可以有益地调节针对呼吸道病毒感染的免疫应答的长双歧杆菌
|
AU2018250206A1
(en)
|
2017-04-05 |
2019-10-31 |
Crestovo Holdings Llc |
Compositions and methods for treating parkinson's disease (PD) and related disorders
|
WO2018187464A1
(en)
|
2017-04-05 |
2018-10-11 |
Crestovo Holdings Llc |
Compositions and methods for treating diverticulitis and related disorders
|
MA48939B1
(fr)
|
2017-05-22 |
2021-06-30 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
JP6978514B2
(ja)
|
2017-05-24 |
2021-12-08 |
フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited |
細菌株を含む組成物
|
CA3064773A1
(en)
|
2017-05-26 |
2018-11-29 |
Crestovo Holdings Llc |
Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
|
CN111107859B
(zh)
|
2017-06-14 |
2022-04-29 |
4D制药研究有限公司 |
包含细菌菌株的组合物
|
EP3638271B1
(de)
|
2017-06-14 |
2020-10-14 |
4D Pharma Research Limited |
Zusammensetzungen mit bakterienstämmen
|
KR20200015575A
(ko)
|
2017-06-14 |
2020-02-12 |
4디 파마 리서치 리미티드 |
세균 균주를 포함하는 조성물
|
AR112328A1
(es)
|
2017-07-05 |
2019-10-16 |
Evelo Biosciences Inc |
Composiciones y métodos para tratamiento de cáncer usando bifidobacterium animalis ssp. lactis
|
CA3072032A1
(en)
*
|
2017-08-07 |
2019-02-14 |
Finch Therapeutics, Inc. |
Compositions and methods for maintaining and restoring a healthy gut barrier
|
AU2018326705A1
(en)
|
2017-08-30 |
2020-03-05 |
Pendulum Therapeutics, Inc. |
Methods and compositions for treatment of microbiome-associated disorders
|
RU2665173C1
(ru)
*
|
2017-09-18 |
2018-08-28 |
Федеральное государственное бюджетное образовательное учреждение высшего образования "Оренбургский государственный медицинский университет" Министерства здравоохранения Российской Федерации |
Способ профилактики атопического дерматита у младенцев путем модуляции микробного механизма гистаминообразования
|
US20200338144A1
(en)
*
|
2017-11-01 |
2020-10-29 |
Biofermin Pharmaceutical Co., Ltd. |
Agent for preventing or treating small intestinal injury induced by non-steroidal anti-inflammatory drug and proton pump inhibitor
|
WO2019103198A1
(ko)
|
2017-11-24 |
2019-05-31 |
주식회사 고바이오랩 |
락토바실러스 퍼멘텀 kbl 375 균주 및 그 용도
|
EP3517119B1
(de)
|
2018-01-26 |
2021-08-11 |
Probisearch, S.L.U. |
Zusammensetzung mit neuem lactobacillus salivarius-stamm und verfahren zur vorbeugung und behandlung von ohrenentzündung und infektionen der oberen atemwege
|
CN112074193A
(zh)
|
2018-01-29 |
2020-12-11 |
精密生物集团有限公司 |
一种用于预防和治疗肠易激综合征的组合产品
|
US20190298783A1
(en)
*
|
2018-03-28 |
2019-10-03 |
Morinaga Milk Industry Co., Ltd. |
Composition for relieving stress, pharmaceutical composition and food and drink composition and method for relieving stress using the composition for relieving stress
|
RU2670054C1
(ru)
*
|
2018-04-24 |
2018-10-17 |
Федеральное государственное бюджетное учреждение науки Институт клеточного и внутриклеточного симбиоза Уральского отделения Российской академии наук |
Штамм бактерий Bifidobacterium bifidum ICIS-310 - продуцент ингибитора провоспалительного цитокина INF-γ
|
SG11202010944RA
(en)
|
2018-05-09 |
2020-12-30 |
Ko Biolabs Inc |
Lactobacillus paracasei strain and use thereof
|
CN113151036B
(zh)
*
|
2018-05-11 |
2024-08-23 |
韩国亿诺生物有限公司 |
具有预防或治疗癌症的效果的新型菌株
|
AU2019274351B2
(en)
|
2018-05-23 |
2022-04-07 |
Kobiolabs, Inc. |
Lactobacillus gasseri KBL697 strain and use thereof
|
WO2019227414A1
(zh)
*
|
2018-05-31 |
2019-12-05 |
深圳华大生命科学研究院 |
一种组合物及其应用
|
US11166990B2
(en)
|
2018-07-13 |
2021-11-09 |
Finch Therapeutics Holdings Llc |
Methods and compositions for treating ulcerative colitis
|
CN109486700A
(zh)
*
|
2018-08-31 |
2019-03-19 |
石家庄君乐宝乳业有限公司 |
副干酪乳杆菌n1115预防结肠炎的应用及相应的益生菌粉、应用
|
CA3114423A1
(en)
|
2018-09-27 |
2020-04-02 |
Finch Therapeutics Holdings Llc |
Compositions and methods for treating epilepsy and related disorders
|
ES2752798B2
(es)
*
|
2018-10-05 |
2020-08-12 |
Consejo Superior Investigacion |
Cepa de Bifidobacterium longum sub. infantis y uso de la misma
|
KR102074445B1
(ko)
|
2018-12-12 |
2020-02-06 |
주식회사 비피도 |
류마티스관절염 개선, 예방 또는 치료를 위한 비피도박테리움 롱검 rapo 균주 및 이를 포함하는 조성물
|
EP4003300A4
(de)
*
|
2019-07-26 |
2023-06-28 |
Infinant Health, Inc |
Nahrhafte zusammensetzungen mit bioaktiven proteinen
|
KR102224072B1
(ko)
*
|
2019-08-19 |
2021-03-10 |
주식회사 빙그레 |
면역 조절능력과 혈중콜레스테롤 감소 능력이 모두 뛰어난 비피도박테리엄 롱검 아종 균주 및 이의 용도
|
CN110547915A
(zh)
*
|
2019-08-29 |
2019-12-10 |
云南白药清逸堂实业有限公司 |
应用益生菌的卫生棉制品及其制备方法
|
CN110452860A
(zh)
*
|
2019-09-24 |
2019-11-15 |
厦门大学 |
一种唾液链球菌及其在治疗炎症性肠病药物中的应用
|
EP4117697A1
(de)
|
2020-03-13 |
2023-01-18 |
PrecisionBiotics Group Limited |
Bifidobacterium longum
|
TWI748395B
(zh)
*
|
2020-03-31 |
2021-12-01 |
豐華生物科技股份有限公司 |
緩解過敏以及提升運動表現之組合物及其用途
|
CN113943681B
(zh)
*
|
2020-11-12 |
2023-07-04 |
江南大学 |
一株降低炎症反应且具有缓解便秘作用的长双歧杆菌
|
KR102307603B1
(ko)
*
|
2020-11-13 |
2021-10-05 |
주식회사 비피도 |
비피도박테리움 롱검 rapo (kctc13773bp)를 포함하는 암 예방 또는 치료용 조성물
|
CN114317310B
(zh)
*
|
2021-03-31 |
2023-09-22 |
江苏蓝泽生物科技有限公司 |
一种抗过敏的婴儿双歧杆菌制剂及其制备方法
|
CN114558037B
(zh)
*
|
2022-02-24 |
2023-08-15 |
同济大学 |
Akk和ls在制备提高认识水平的抗衰老产品中的应用
|
CN115725456B
(zh)
*
|
2022-10-11 |
2024-06-21 |
四川大学 |
一种唾液乳杆菌及其应用
|